Showing 1 - 8 results of 8 for search 'Alberto Chiappori', query time: 0.03s Refine Results
  1. 1
    Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)

    Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC) by Andreas Saltos, Michael Shafique, Alberto Chiappori

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study

    Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study by Luigi Aurisicchio, Arthur Fridman, David Mauro, Rose Sheloditna, Alberto Chiappori, Ansuman Bagchi, Gennaro Ciliberto

    Published 2020-01-01
    Get full text
    Article
  3. 3
    Treatment Strategies for Non-Small Cell Lung Cancer with Common <i>EGFR</i> Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data

    Treatment Strategies for Non-Small Cell Lung Cancer with Common <i>EGFR</i> Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data by Julian A. Marin-Acevedo, Bruna Pellini, ErinMarie O. Kimbrough, J. Kevin Hicks, Alberto Chiappori

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy

    Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy by Dung-Tsa Chen, Andreas N. Saltos, Trevor Rose, Zachary J. Thompson, Ram Thapa, Alberto Chiappori, Jhanelle E. Gray

    Published 2023-04-01
    Get full text
    Article
  5. 5
    603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

    603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LU... by Jyoti Malhotra, Alberto Chiappori, Salma K Jabbour, Chunxia Chen, Naomi Fujioka, Nasser H Hanna, Lawrence E Feldman, Malini Patel, Dirk Moore

    Published 2023-11-01
    Article
  6. 6
    702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer

    702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer by Zhonglin Hao, Alberto Chiappori, Adam Schoenfeld, Paul Schwarzenberger, Jacob Sands, Lida Pacaud, Christopher delCorral, Dong Geng, Zhong Yun, Chaun Wang, Gianni Amato, Sahista Vahora

    Published 2023-11-01
    Article
  7. 7
    Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299

    Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299 by Arkadiusz Z. Dudek, MD, PhD, Min X. Xi, PhD, Katherine A. Scilla, MD, Hirva Mamdani, MD, Benjamin C. Creelan, MD, Andreas Saltos, MD, Tawee Tanvetyanon, MD, Alberto Chiappori, MD

    Published 2023-12-01
    Get full text
    Article
  8. 8
    Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer

    Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer by Nitin Roper, Moises J. Velez, Alberto Chiappori, Yoo Sun Kim, Jun S. Wei, Sivasish Sindiri, Nobuyuki Takahashi, Deborah Mulford, Suresh Kumar, Kris Ylaya, Christopher Trindade, Irena Manukyan, Anna-Leigh Brown, Jane B. Trepel, Jung-Min Lee, Stephen Hewitt, Javed Khan, Anish Thomas

    Published 2021-06-01
    Get full text
    Article

Search Tools: